EUVIMEDEUVIMED entdecken
Open Access

Zafirlukast, as a viral inactivator, potently inhibits infection of several flaviviruses, including Zika virus, dengue virus, and yellow fever virus

Yongkang Chen iD, Yuan Li, Lu Lu iD, Peng Zou iD

Antimicrobial Agents and Chemotherapy · 2024

DOI: 10.1128/aac.00168-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2024. Verfasst von Yongkang Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Public Health Clinical Center, Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), Shanghai Institute of Infectious Disease and Bio…. Hauptthemen laut MEDLINE: Zika Virus, Antiviral Agents, Dengue Virus, Yellow fever virus. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Key Research and Development Program of China, Shanghai Municipal Science and Technology Major Project, Shanghai Public Health Clinical Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Zika virus (ZIKV) is one of the mosquito-borne flaviviruses that exhibits a unique tropism to nervous systems and is associated with Guillain-Barre syndrome and congenital Zika syndrome (CZS). Dengue virus (DENV) and yellow fever virus (YFV), the other two mosquito-borne flaviviruses, have also been circulating for a long time and cause severe diseases, such as dengue hemorrhagic fever and yellow fever, respectively. However, there are no safe and effective antiviral drugs approved for the treatment of infections or coinfections of these flaviviruses. Here, we found that zafirlukast, a pregnancy-safe leukotriene receptor antagonist, exhibited potent antiviral activity against infections of ZIKV strains from different lineages in different cell lines, as well as against infections of DENV-2 and YFV 17D. Mechanistic studies demonstrated that zafirlukast directly and irreversibly inactivated these flaviviruses by disrupting the integrity of the virions, leading to the loss of viral infectivity, hence inhibiting the entry step of virus infection. Considering its efficacy against flaviviruses, its safety for pregnant women, and its neuroprotective effect, zafirlukast is a promising candidate for prophylaxis and treatment of infections or coinfections of ZIKV, DENV, and YFV, even in pregnant women.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Zika VirusAntiviral AgentsDengue VirusYellow fever virusIndolesSulfonamidesHumansAnimalsChlorocebus aethiopsVero CellsZika Virus InfectionCell LinePhenylcarbamates

Stichwörter der Autor:innen

Zika virusantiviralsdengue virusentry inhibitorinactivatoryellow fever viruszafirlukastflavivirus

Substanzen

Antiviral AgentsIndoleszafirlukastSulfonamidesPhenylcarbamates

Autor:innen und Institutionen

  • Shanghai Public Health Clinical Center, Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), Shanghai Institute of Infectious Disease and Biosecurity, School of Basic Medical Sciences, Fudan University, Shanghai…

ORCID-Profile: Yongkang Chen, Lu Lu, Peng Zou

Förderung

  • National Key Research and Development Program of China
  • Shanghai Municipal Science and Technology Major Project
  • Shanghai Public Health Clinical Center

Zitieren

APA

Chen, Y., Li, Y., Lu, L., & Zou, P. (2024). Zafirlukast, as a viral inactivator, potently inhibits infection of several flaviviruses, including Zika virus, dengue virus, and yellow fever virus. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00168-24

Vancouver

Chen Y, Li Y, Lu L, Zou P. Zafirlukast, as a viral inactivator, potently inhibits infection of several flaviviruses, including Zika virus, dengue virus, and yellow fever virus. Antimicrobial Agents and Chemotherapy. 2024. doi:10.1128/aac.00168-24

BibTeX
@article{Chen2024,
  author = {Chen, Yongkang and Li, Yuan and Lu, Lu and Zou, Peng},
  title = {Zafirlukast, as a viral inactivator, potently inhibits infection of several flaviviruses, including Zika virus, dengue virus, and yellow fever virus},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2024},
  doi = {10.1128/aac.00168-24}
}
Kostenlos starten →